Is this you? Create Your Porfile
Avatar

Jana Lenz

Bayer HealthCare Pharmaceuticals

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Jana Lenz is active.

Explore More

Publication

Featured researches published by Jana Lenz.

Archive | 2005

Thermodynamically stable form of bay 43-9006 tosylate

Alfons Grunenberg; Jana Lenz

Archive | 2005

Process for the preparation of 4-{4-[({[4 chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide

Michael Lögers; Reinhold Gehring; Oliver Kuhn; Mike Matthäus; Klaus Mohrs; Matthias Müller-Gliemann; Jürgen Stiehl; Mathias Berwe; Jana Lenz; Werner Heilmann

Archive | 2006

NOVEL POLYMORPHOUS FORM AND THE AMORPHOUS FORM OF 5-CHLORO-N-({ (5S)-2-OXO-3[4-(3-OXO-4-MORPHOLINYL(-PHENYL]-1,3-OXAZOLIDINE-5-YL}-METHYL)-2-THIOPHENE CARBOXAMIDE

Alfons Grunenberg; Jana Lenz; Gerhard Arnold Braun; Birgit Keil; Christian R. Thomas

Archive | 2005

PROCESS FOR THE PREPARATION OF 4- {4 - [({[4-chloro-3- (trifluoromethyl) phenyl] AMINO} CARBONYL) AMINO] PHENYOXY} N-methylpyridine-2-carboxamide

Michael Lögers; Reinhold Gehring; Oliver Kuhn; Mike Matthäus; Klaus Mohrs; Matthias Dr. Müller-Gliemann; Jürgen Stiehl; Mathias Berwe; Jana Lenz; Werner Heilmann

Archive | 2006

Polymorphous form of 5-chloro-N-({(5S)-2-oxo-3[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide

Alfons Grunenberg; Jana Lenz; Gerhard Arnold Braun; Birgit Keil; Christian R. Thomas

Archive | 2006

NEUE POLYMORPHE FORM VON 5-CHLOR-N-(ä ( 5S )-2-0X0-3-Ä4-( 3-OXO-4-MORPHOLINYL)-PHENYLÜ-1,3-OXAZOLIDIN-5-YLü -METHYL)-2-THIOPHENCARBOXAMID

Alfons Grunenberg; Jana Lenz; Gerhard Arnold Braun; Birgit Keil; Christian R. Thomas

Archive | 2005

Crystalline Modifications of N-Alpha-(2,4,6-Triisopropylphenylsulfonyl)-3-Hydroxyamidino- (L)- Phenylalanine 4-Ethoxycarbonylpiperazide And/Or Salts Thereof

Alfons Grunenberg; Jana Lenz

Archive | 2012

METHOD FOR MANUFACTURING 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE

Michael Dr Loegers; ミヒャエル・レーゲルス; Reinhold Gehring; ラインホルト・ゲーリング; Oliver Kuhn; オリヴァー・クーン; Mike Matthaeus; ミケ・マットホイス; Klaus Mohrs; クラウス・モーアス; Matthias Dr Mueller-Gliemann; マティアス・ミューラー−グリーマン; Juergen Stiehl; ユルゲン・シュティール; Mathias Berwe; マティアス・ベルヴェ; Jana Lenz; ヤーナ・レンツ; Werner Heilmann; ヴェルナー・ハイルマン

Archive | 2006

Neue polymorphe form und die amorphe form von 5-chlor-n- ( { ( 5s ) -2-0x0-3-[4-( 3-oxo-4-morpholinyl) - phenyl] -1,3-oxazolidin-5-yl} -methyl) -2- thiophencarboxamid

Alfons Grunenberg; Jana Lenz; Gerhard Arnold Braun; Birgit Keil; Christian R. Thomas

Archive | 2006

Nouvelle forme polymorphe de 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide

Alfons Grunenberg; Jana Lenz; Gerhard Arnold Braun; Birgit Keil; Christian R. Thomas

Explore More

Collaboration

Dive into the Jana Lenz's collaboration.

Top Co-Authors
Avatar

Alfons Grunenberg

Bayer

View shared research outputs
Top Co-Authors
Avatar

Birgit Keil

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

Christian R. Thomas

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Gerhard Arnold Braun

Bayer Corporation

View shared research outputs
Top Co-Authors
Avatar

Oliver Kuhn

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Klaus Mohrs

University of Bonn

View shared research outputs
Top Co-Authors
Avatar

Reinhold Gehring

Bayer

View shared research outputs
Top Co-Authors
Avatar

Werner Heilmann

Bayer

View shared research outputs
Top Co-Authors
Avatar

Jürgen Stiehl

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Mathias Berwe

Bayer Corporation

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge